Cargando…

Surgical Compliance and Survival Outcomes for Patients with Stage T1-2 Non-Small-Cell Lung Cancer

INTRODUCTION: Our aim was to determine the relationship between surgical compliance and survival outcomes in patients with stage T1-2 non-small-cell lung cancer (NSCLC). METHODS: Patients with T1-2 NSCLC who were diagnosed between 2004 and 2015 were identified from the SEER database. Multivariate l...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Siben, Mao, Weipu, Wang, Yi, Shi, Xiuquan, Wang, Wei, Dai, Lili, Zhang, Wenping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245446/
https://www.ncbi.nlm.nih.gov/pubmed/32547197
http://dx.doi.org/10.2147/CMAR.S238819
_version_ 1783537761032077312
author Wang, Siben
Mao, Weipu
Wang, Yi
Shi, Xiuquan
Wang, Wei
Dai, Lili
Zhang, Wenping
author_facet Wang, Siben
Mao, Weipu
Wang, Yi
Shi, Xiuquan
Wang, Wei
Dai, Lili
Zhang, Wenping
author_sort Wang, Siben
collection PubMed
description INTRODUCTION: Our aim was to determine the relationship between surgical compliance and survival outcomes in patients with stage T1-2 non-small-cell lung cancer (NSCLC). METHODS: Patients with T1-2 NSCLC who were diagnosed between 2004 and 2015 were identified from the SEER database. Multivariate logistic regression was used to analyse factors associated with surgical compliance. Kaplan–Meier curves and Cox regression were used to analyse the effects of surgical compliance on overall survival (OS) and cancer-specific survival (CSS). RESULTS: Of the 221,704 eligible T1-2 NSCLC patients, 106,668 patients recommended surgery. Among them, 99,672 (93.4%) patients were surgical compliance group, and 6996 (6.6%) were surgical noncompliance group. Poor surgical compliance was associated with earlier diagnosis time, old age, male, black race, unmarried status, main bronchus site, poor grade/stage, and lower household income. Patients’ compliance was an independent prognostic factor for OS and CSS of T1-2 NSCLC patients. Multivariate Cox regression showed that surgical noncompliance individuals showed lower OS (hazard ratio [HR] 2.494; 95% confidence interval [CI] 2.423–2.566, p < 0.001) and lower CSS (HR 2.877; 95% CI 2.782–2.974, p < 0.001) compared with surgical compliance patients. In addition, results in the non-surgical group were observed to be similar to those of the surgical noncompliance group. CONCLUSION: We found that patients’ compliance was an independent prognostic factor for survival in T1-2 NSCLC patients. Poor surgical compliance was associated with earlier diagnosis time, old age, male, black race, unmarried status, main bronchus site, poor grade/stage, and lower household income.
format Online
Article
Text
id pubmed-7245446
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-72454462020-06-15 Surgical Compliance and Survival Outcomes for Patients with Stage T1-2 Non-Small-Cell Lung Cancer Wang, Siben Mao, Weipu Wang, Yi Shi, Xiuquan Wang, Wei Dai, Lili Zhang, Wenping Cancer Manag Res Original Research INTRODUCTION: Our aim was to determine the relationship between surgical compliance and survival outcomes in patients with stage T1-2 non-small-cell lung cancer (NSCLC). METHODS: Patients with T1-2 NSCLC who were diagnosed between 2004 and 2015 were identified from the SEER database. Multivariate logistic regression was used to analyse factors associated with surgical compliance. Kaplan–Meier curves and Cox regression were used to analyse the effects of surgical compliance on overall survival (OS) and cancer-specific survival (CSS). RESULTS: Of the 221,704 eligible T1-2 NSCLC patients, 106,668 patients recommended surgery. Among them, 99,672 (93.4%) patients were surgical compliance group, and 6996 (6.6%) were surgical noncompliance group. Poor surgical compliance was associated with earlier diagnosis time, old age, male, black race, unmarried status, main bronchus site, poor grade/stage, and lower household income. Patients’ compliance was an independent prognostic factor for OS and CSS of T1-2 NSCLC patients. Multivariate Cox regression showed that surgical noncompliance individuals showed lower OS (hazard ratio [HR] 2.494; 95% confidence interval [CI] 2.423–2.566, p < 0.001) and lower CSS (HR 2.877; 95% CI 2.782–2.974, p < 0.001) compared with surgical compliance patients. In addition, results in the non-surgical group were observed to be similar to those of the surgical noncompliance group. CONCLUSION: We found that patients’ compliance was an independent prognostic factor for survival in T1-2 NSCLC patients. Poor surgical compliance was associated with earlier diagnosis time, old age, male, black race, unmarried status, main bronchus site, poor grade/stage, and lower household income. Dove 2020-05-19 /pmc/articles/PMC7245446/ /pubmed/32547197 http://dx.doi.org/10.2147/CMAR.S238819 Text en © 2020 Wang et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Wang, Siben
Mao, Weipu
Wang, Yi
Shi, Xiuquan
Wang, Wei
Dai, Lili
Zhang, Wenping
Surgical Compliance and Survival Outcomes for Patients with Stage T1-2 Non-Small-Cell Lung Cancer
title Surgical Compliance and Survival Outcomes for Patients with Stage T1-2 Non-Small-Cell Lung Cancer
title_full Surgical Compliance and Survival Outcomes for Patients with Stage T1-2 Non-Small-Cell Lung Cancer
title_fullStr Surgical Compliance and Survival Outcomes for Patients with Stage T1-2 Non-Small-Cell Lung Cancer
title_full_unstemmed Surgical Compliance and Survival Outcomes for Patients with Stage T1-2 Non-Small-Cell Lung Cancer
title_short Surgical Compliance and Survival Outcomes for Patients with Stage T1-2 Non-Small-Cell Lung Cancer
title_sort surgical compliance and survival outcomes for patients with stage t1-2 non-small-cell lung cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245446/
https://www.ncbi.nlm.nih.gov/pubmed/32547197
http://dx.doi.org/10.2147/CMAR.S238819
work_keys_str_mv AT wangsiben surgicalcomplianceandsurvivaloutcomesforpatientswithstaget12nonsmallcelllungcancer
AT maoweipu surgicalcomplianceandsurvivaloutcomesforpatientswithstaget12nonsmallcelllungcancer
AT wangyi surgicalcomplianceandsurvivaloutcomesforpatientswithstaget12nonsmallcelllungcancer
AT shixiuquan surgicalcomplianceandsurvivaloutcomesforpatientswithstaget12nonsmallcelllungcancer
AT wangwei surgicalcomplianceandsurvivaloutcomesforpatientswithstaget12nonsmallcelllungcancer
AT dailili surgicalcomplianceandsurvivaloutcomesforpatientswithstaget12nonsmallcelllungcancer
AT zhangwenping surgicalcomplianceandsurvivaloutcomesforpatientswithstaget12nonsmallcelllungcancer